Ductal Carcinoma In Situ Active Not Recruiting Phase 2 Trials for Naltrexone (DB00704)

Also known as: Ductal carcinoma in situ / [M]Intraductal carcinoma, non-infiltrating NOS / Carcinoma, Intraductal, Noninfiltrating / Carcinoma in situ of breast ductal / Intraductal carcinoma in situ of breast / Intraductal proliferative breast lesion

DBCOND0037614 (Ductal Carcinoma In Situ)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02137252Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast CancerSupportive Care